These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 2257720

  • 41. Effects on ACE inhibitor therapy on derived central arterial waveforms in hypertension.
    O'Rourke MF.
    Am J Hypertens; 2002 May; 15(5):476-7; author reply 477. PubMed ID: 12022254
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Inhibition of the angiotensin-converting enzyme--effect on kidney function and electrolyte balance].
    Kramer HJ.
    Z Kardiol; 1988 May; 77 Suppl 3():39-45. PubMed ID: 3062959
    [Abstract] [Full Text] [Related]

  • 46. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 52. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones.
    Kramer HJ, Glänzer K, Meyer-Lehnert H, Mohaupt M, Predel HG.
    J Cardiovasc Pharmacol; 1990 Sep; 15 Suppl 6():S91-8. PubMed ID: 1697369
    [Abstract] [Full Text] [Related]

  • 53. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
    Klaus D.
    Z Kardiol; 1988 Sep; 77 Suppl 3():73-88. PubMed ID: 3062960
    [Abstract] [Full Text] [Related]

  • 54. Angiotensin-converting enzyme inhibition in patients with essential hypertension.
    Kramer HJ, Predel HG, Meyer-Lehnert H.
    Clin Physiol Biochem; 1990 Sep; 8 Suppl 1():16-24. PubMed ID: 2257720
    [Abstract] [Full Text] [Related]

  • 55. [Inhibition of the angiotensin-converting enzyme--effect on kidney function and electrolyte balance].
    Kramer HJ.
    Z Kardiol; 1988 Sep; 77 Suppl 3():39-45. PubMed ID: 3062959
    [Abstract] [Full Text] [Related]

  • 56. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 57. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones.
    Kramer HJ, Glänzer K, Meyer-Lehnert H, Mohaupt M, Predel HG.
    J Cardiovasc Pharmacol; 1990 Sep; 15 Suppl 6():S91-8. PubMed ID: 1697369
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.